Sivik Global Healthcare’s Loxo Oncology, Inc LOXO Stock Holding History

Sivik Global Healthcare’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,000	Closed	-$1.4M	–	68
2018 Q4	$1.4M	Sell	10,000 -5,000	-33%	-$759K	0.76%	41
2018 Q3	$2.56M	Sell	15,000 -5,000	-25%	-$840K	0.91%	46
2018 Q2	$3.47M	Buy	20,000 +2,500	+14%	+$376K	1.33%	38
2018 Q1	$2.02M	Hold	17,500	–	–	0.94%	45
2017 Q4	$1.47M	Sell	17,500 -7,500	-30%	-$625K	0.55%	64
2017 Q3	$2.3M	Buy	25,000 +4,500	+22%	+$350K	0.78%	50
2017 Q2	$1.64M	Buy	+20,500	New	+$1.14M	0.6%	57

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Sivik Global Healthcare's LOXO Position: Q1 2019 in Review

Sivik Global Healthcare sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 10,000 shares — an estimated $1.4M sold.

Sivik Global Healthcare first reported a position in LOXO in Q2 2017 and held it in 7 quarters. The position peaked at $3.47M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Sivik Global Healthcare reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Sivik Global Healthcare sold 10,000 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.4M.
Sivik Global Healthcare first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 7 quarters.
Sivik Global Healthcare's Loxo Oncology, Inc position peaked at $3.47M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Sivik Global Healthcare's 13F filing for Q1 2019, filed 8 May 2019.